Human-relevant 3D tumour models designed to support therapeutic evaluation, translational research, and more informed preclinical decision-making.
With our extensive repository of tumor biopsies and sourcing capabilities, we can provide the specific cancer indications required for your study.
These biopsies are then utilized to 3D-print tumors tailored to your research needs.
If you have already sourced your material, cell line, or patient tissue, we can utilize these to 3D-print tumors.
Harness the power of precision with our assay-ready, cancer models, part of our comprehensive preclinical oncology services.
We create patient-derived tumors that retain their native microenvironment, offering you highly relevant models for drug testing, optimization, and precision medicine.
Bridge resource gaps and accelerate your research with our expert scientific team.
We design and execute assays on your behalf, delivering the critical insights you need, faster and with precision.
Traditional models often force researchers to choose between biological relevance and experimental reproducibility. Our 3D bioprinted tumour models are designed to deliver both, using established cancer cell lines and fresh patient-derived tissue in assay-ready formats suitable for oncology research.
Fresh tumour tissue incorporated into biologically relevant 3D tumour models.
Established cancer cell lines bioprinted into reproducible 3D tumour models.
Compatible with imaging, molecular analysis and therapeutic evaluation.
We provide comprehensive solid-tumour research services to advance drug development and enhance personalized therapy decisions.
